Clinical trials: Geriatric Cancer Patients
Confort, Older Adults With Cancer
Enhancing Patient Experience in Geriatric Oncology
Approximately 60% of new cancer diagnoses and 70% of cancer-related deaths occur in adults aged 65 years and older, a population frequently affected by multimorbidity, frailty, sensory impairment, and treatment-related symptom…
- Trial name
- NCT07671586
- Testing
- Comfort menu and cart implemented
- Where
- Brazil
- Volunteers
- 264 people
- Sponsor
- Hospital Sirio-Libanes
Stomach Neoplasms, Colonic Neoplasms
Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients
Postoperative delirium（POD）is a common complication that can directly affect important clinical outcomes, and exert an enormous burden on patients, their families, hospitals, and public resources.
- Conditions
- Stomach Neoplasms, Colonic Neoplasms, Rectal Neoplasms, Sigmoid Neoplasms
- Trial name
- NCT05068180
- Testing
- low-dose neuroleptanalgesia
- Where
- 2 sites in China
- Volunteers
- 200 people
- Sponsor
- RenJi Hospital
Acute Myeloid Leukemia
Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML
The purpose of this study is to determine whether Azacitidine consolidation is superior to standard DA consolidation treatment of acute myeloid leukemia in first complete remission in elderly patients.
- Trial name
- NCT01794169
- Testing
- Azacitidine, DA
- Where
- Sweden
- Volunteers
- 130 people
- Sponsor
- Karolinska University Hospital
Acute Myeloid Leukemia
Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen for Elderly Patients With Acute Myeloid Leukemia: A Phase II Single-Arm Multicenter Study
Acute myeloid leukemia (AML) is a disease affecting older adults, although optimal strategies for treating such patients remain unclear.
- Trial name
- NCT05258799
- Testing
- rhTPO
- Where
- China
- Volunteers
- 130 people
- Sponsor
- Huihan Wang
Cancer
Assessment of Frailty in Elderly Patients With Advanced Cancers
This study is looking at the feasibility of performing frailty assessments on elderly patients with advanced cancers
- Trial name
- FAC-C (NCT02482285)
- Where
- United Kingdom
- Volunteers
- 8 people
- Sponsor
- Newcastle-upon-Tyne Hospitals NHS Trust
NSCLC (Non-small Cell Lung Cancer)
Serplulimab Monotherapy in Elderly Patients With NSCLC and PD-L1 TPS ≥ 50%
This prospective clinical study aims to evaluate and observe the efficacy and safety of Serplulimab Monotherapy in Elderly Patients with NSCLC and PD-L1 TPS ≥ 50% using a multicenter, single-arm, phase II design.
- Trial name
- NCT07596121
- Testing
- Serplulimab
- Where
- China
- Volunteers
- 60 people
- Sponsor
- Tang-Du Hospital
High Risk Acute Myeloid Leukemia
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
To confirm the efficacy of CPX-351 compared to 7+3 as first line therapy in elderly patients (60-75 yrs) with high risk (secondary) Acute Myeloid Leukemia. The primary efficacy endpoint will be overall survival.
- Trial name
- 301 (NCT01696084)
- Testing
- CPX-351, 7+3 (cytarabine and daunorubicin)
- Where
- 43 sites in United States, Canada
- Volunteers
- 309 people
- Sponsor
- Jazz Pharmaceuticals
Primary Non Hodgkin Lymphoma of the Central Nervous System
Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma
The purpose of this study is to determine whether combined chemotherapy [rituximab plus high dosage methotrexate, lomustine, and procarbazine] followed by maintenance therapy with procarbazine is effective in the treatment of…
- Trial name
- PRIMAIN (NCT00989352)
- Testing
- Methotrexate, Lomustine, Procarbazine
- Where
- Germany
- Volunteers
- 56 people
- Sponsor
- University Hospital Freiburg
Acute Myeloid Leukemia, Myelodysplastic Syndromes
DNA Hypomethylating Agents and Lenalidomide in Elderly Patients With Myeloid Malignancies in the US
The study aims to comprehensively analyze data from a large and unselected older AML population in the US, both treated and untreated.
- Trial name
- NCT02863458
- Where
- United States
- Sponsor
- The Cleveland Clinic
Predicting Chemotherapy Related Toxicity in Elderly Patients
G8, VES-13 and CARG Scores in Predicting Chemotherapy Toxicity in Geriatric Cancer Patients
All participants' medical information will be collected for use as a baseline, including tumor-specific variables, nutritional status, functional status, psychological status, cognitive function, social support, and…
- Trial name
- NCT04992455
- Testing
- Older Patients Receiving Chemotherapy
- Where
- Turkey (Türkiye)
- Volunteers
- 150 people
- Sponsor
- Namik Kemal University
Elderly Patients, Breast Cancer
Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study
Determination of guidelines regarding the use of adjuvant chemotherapy for early breast cancer in this population of Patients over 70 years old.
- Trial name
- NCT00263705
- Testing
- Adjuvant capecitabine, capecitabine in aduvant setting
- Where
- Belgium
- Volunteers
- 43 people
- Sponsor
- Jules Bordet Institute
Diffuse Large B-Cell Lymphoma
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
The study will measure the safety, tolerability, and efficacy with acalabrutinib in combination with rituximab in treatment-naïve elderly and/or frail patients with diffuse large B-cell lymphoma (DLBCL), who are otherwise…
- Trial name
- ACRUE (NCT05952024)
- Testing
- Acalabrutinib, Rituximab
- Where
- 57 sites in United States, Brazil and 3 more
- Volunteers
- 80 people
- Sponsor
- AstraZeneca
Acute Myeloid Leukemia
Decitabine and Plerixafor in Elderly Acute Myeloid Leukemia (AML)
The hypothesis of this proposal is that combining plerixafor, an inhibitor of stromal cell derived factor - 1α (SDF-1α), with decitabine, a DNA methyltransferase inhibitor, as induction and postremission therapy for older…
- Trial name
- NCT01352650
- Testing
- plerixafor, decitabine
- Where
- United States
- Volunteers
- 71 people
- Sponsor
- Weill Medical College of Cornell University
Colorectal Cancer
RCT on Elderly Patients Undergoing Colorectal Cancer Surgery With Enhanced Geriatric Care
This study evaluates the effects of enhanced geriatric input on elderly patients undergoing colorectal cancer surgery. Half of the participants will received additional pre, peri and post-operative care from the geriatric team…
- Trial name
- NCT02352688
- Testing
- Enhanced Colorectal Geriatric Care
- Where
- Hong Kong
- Volunteers
- 74 people
- Sponsor
- Chinese University of Hong Kong
Acute Myeloid Leukemia
Combined PD1 Inhibitor and Decitabine in Elderly Patients With Relapse and Refractory Acute Myeloid Leukemia
This is an open-label, single arm, phase 2 study to evaluate efficacy and safety of PD1 inhibitor Camrelizumab(SHR-1210) combined with DNA methyltransferase inhibitor decitabine in elderly patients with relapse and refractory…
- Trial name
- NCT04353479
- Testing
- Camrelizumab(SHR-1210), Decitabine
- Volunteers
- 29 people
- Sponsor
- Shanghai Jiao Tong University School of Medicine
Elderly Cancer Patients, Cognitive Impairment
Validation of the Freund Clock Drawing Test to Screen for Cognitive Dysfunction in Cancer Patients
A Comprehensive Geriatric Assessment (CGA) has become a fundamental aid in the evaluation and treatment planning of older cancer patients.
- Trial name
- PROACTIVE (NCT01749995)
- Where
- Belgium
- Volunteers
- 200 people
- Sponsor
- General Hospital Groeninge
Parkinson's Disease (PD), Mild to Moderate Parkinson's Disease
A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.
The goal of this trial is to learn if MTX325 can be developed as a potential disease-modifying treatment for Parkinson's Disease. Parts 1-4 complete, Part 5 (multiple doses in patients with Parkinson's Disease) in progress.
- Conditions
- Parkinson's Disease (PD), Mild to Moderate Parkinson's Disease, Early Stage Parkinson's Disease
- Trial name
- NCT07630545
- Testing
- MTX325
- Where
- 18 sites in Australia, France and 2 more
- Volunteers
- 106 people, healthy volunteers welcome
- Sponsor
- Mission Therapeutics
Acute Myeloid Leukemia
Gemtuzumab Ozogamicin+Cytarabine vs Idarubicin+Cytarabine in Elderly Patients With AML.Mylofrance 4
Purpose : The main objective of this study is to assess the efficacy and tolerance of the addition of repeated doses of low doses (3mg/m2) of Gemtuzumab Ozogamicin (GO) in addition with standard doses of Ara-C in previously…
- Trial name
- ALFA1401 (NCT02473146)
- Testing
- Gemtuzumab ozogamicin (GO)
- Where
- 21 sites in France
- Volunteers
- 225 people
- Sponsor
- Versailles Hospital
Elderly Patients (>65 Years), Non-Small Cell Lung Cancer
Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC
The goal of this clinical trial is to elucidate the clinical efficacy and safety of electroacupuncture combined with PD-1 inhibitor therapy in elderly patients with advanced non-small cell lung cancer (NSCLC) through a…
- Conditions
- Elderly Patients (>65 Years), Non-Small Cell Lung Cancer, PD-1 Inhibitors, Electroacupuncture
- Trial name
- NCT07086300
- Testing
- Electroacupuncture (EA)
- Where
- China
- Volunteers
- 120 people
- Sponsor
- Kong Fanming
Esophageal Cancer, Nimotuzumab
Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients
Elderly or malnourished patients diagnosed with locally advanced esophageal squamous cell carcinoma (ESCC) had poor prognosis. Radiotherpy was an important and effective treatment in treating ESCC.
- Conditions
- Esophageal Cancer, Nimotuzumab, Chemoradiotherapy, Chemotherapy
- Trial name
- NCT06429839
- Testing
- Nimotuzumab with chemoradiotherapy
- Where
- China
- Volunteers
- 55 people
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.